Skip to content

Regeneron Pharmaceuticals REGN Total Cost of Revenue

Total Cost of Revenue at other companies

Merck & Co. logo
Merck & Co.MRK
$4.2B+22.7%
Amgen logo
AmgenAMGN
$2.74B-7.5%
Glaukos logo
GlaukosGKOS
$33.34M+37.1%
Precigen logo
PrecigenPGEN
$10.64M+20.1%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$1.33M+5.3%

Other financials

Income statement

See full
Revenue$3.6B+19.0%
Operating income$642.9M+8.7%
Net income$727.2M-10.1%
EPS (diluted)$6.75-7.2%

Balance sheet

See full
Cash & equivalents$3.0B-4.0%
Total debt$2.7B+0.1%
Total equity$31.4B+6.9%
Total assets$40.9B+8.9%

Cash flow

See full
Operating cash flow$1.1B+3.2%
CapEx$230.6M+0.6%
Free cash flow$848.3M+4.0%

Valuation

See full
Market cap$65.01B+18.1%
Enterprise value$64.75B+18.5%
P/E14.7×+2.5×
P/S4.4×+0.5×

Profitability

See full
Gross margin93.9%
Operating margin24.3%-2.9pp
Net margin29.6%-2.3pp
FCF margin27.6%+5.5pp

Returns & leverage

See full
Return on equity14.5%-1.4pp
Debt / equity0.1×0.0×
Current ratio3.6×-1.4×

Where this comes from

Reported directly by Regeneron Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.

The official record: Regeneron Pharmaceuticals’s 10-K, filed February 8, 2021, on SEC EDGAR. View the filing →

Questions, answered.

What does total cost of revenue mean?
The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.